A Oneindia Venture
Click it and Unblock the Notifications
Sharma East India Hospitals & Medical Research Ltd. के निदेशक की रिपोर्ट
Mar 31, 2025
(Rs. in Lakhs)
Your Directors have pleasure in submitting their Thirty Sixth Annual Report on the business and
operations of your Company together with the Audited Financial Statements for the year ended 31st
March, 2025.
1. FINANCIAL SUMMARY / HIGHLIGHTS
|
For the year ended on |
||
|
2024-2025 |
2023-2024 |
|
|
Revenue from Operations & Other Income |
3,018.59 |
2,383.00 |
|
Profit before Interest, Depreciation & Tax |
396.53 |
343.10 |
|
Less: Interest |
71.60 |
94.69 |
|
Operating Profit |
324.93 |
248.41 |
|
Less: Depreciation |
183.65 |
148.04 |
|
Net Profit before Tax |
141.28 |
100.37 |
|
Add/(Less): Tax Expense |
||
|
Current Tax |
23.58 |
15.99 |
|
Deferred Tax |
(6.67) |
4.64 |
|
Adjustment of taxes of earlier years |
(0.06) |
13.44 |
|
Net Profit After Tax |
124.43 |
66.30 |
|
Add: Other Comprehensive Income |
0.00 |
0.00 |
|
Less: Income Tax relating to Other Comprehensive Income |
0.00 |
0.00 |
|
Add: Surplus brought forward from Previous Year |
707.49 |
641.19 |
|
Surplus carried forward to Balance Sheet |
831.92 |
707.49 |
|
Earnings Per Share (Basic & Diluted) |
3.79 |
2.02 |
2. REVIEW OF BUSINESS OPERATIONS AND FUTURE PROSPECTS
The Company''s Total Income i.e. Revenue from Operations and Other Income are Rs. 3,018.59
Lakhs and the profit after tax (including Other Comprehensive Income) is Rs. 124.43 Lakhs
during the current year.
Further your Company has been continuously making efforts to enhance the operations and also
trying to hold its grip over upcoming opportunities in Medical & Health Industry.
3. DIVIDEND
Your Directors have considered it financially prudent in the long-term interests of the Company
to reinvest the profits into the business to build a strong reserve base and grow the business of
the Company. Further, in view of marginal funds, the Board of Directors doesn''t recommended
payment of dividend for the year under review.
4. TRANSFER TO RESERVES
No amount has been transferred to General Reserve during the year. The company carries
reserves of Rs. 831.92 Lakhs under the head "Other Equityâ at the end of the financial year 2024¬
25.
5. SIGNIFICANT MATERIAL CHANGES AFTER BALANCE SHEET DATE AFFECTING FINANCIAL
POSITION
There are no changes and commitments affecting the financial position of the company which have
occurred between the date of Balance Sheet i.e. 31.03.2025 and the date of this report.
6. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS
AND OUTGO
Details pertaining to Conservation of Energy and Technology Absorption as required under
Section 134 (3) (m) of the Companies Act, 2013 read with Rule 8 of the Companies (Accounts)
Rules, 2014 are as follows: -
(A) Conservation of Energy: The operations of the company are not energy intensive. We regularly
evaluate and use new energy efficient technologies and make necessary investment in energy
saving equipments to make our infrastructure more energy-efficient. The company is
continuously striving to conserve the energy at its all levels.
(B) Technology Absorption: Your Company strives for latest technology for its processes and also
strives to achieve full technology absorption.
There were no foreign exchange earnings and outgo during the financial year.
7. DEVELOPMENT AND IMPLEMENTATION OF RISK MANAGEMENT POLICY OF THE COMPANY
The Risk Management of the Company is overseen by the Board of Directors at various levels
and the policy of the Company on Risk Management is provided in this Annual Report in
Management Discussion and Analysis Report.
8. CORPORATE SOCIAL RESPONSIBILITIES (CSR)
The Company does not meet the criteria of Section 135 of Companies Act, 2013 read with the
Companies (Corporate Social Responsibility Policy) Rules, 2014. The Company has not developed
and implemented any Corporate Social Responsibility policy as the said provisions are not
applicable to the Company.
9. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE UNDER SECTION 186 OF
THE COMPANIES ACT, 2013
Details of loans, investments and guarantees covered under the provisions of Section 186 of
Companies Act 2013 are given in the Notes forming part of Financial Statements.
10. PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES
All related party transactions that were entered into during the financial year were on an arm''s
length basis and were in the ordinary course of business (refer Notes forming part of Financial
Statements).
The details forming part of the Related Parties Transactions under Section 188(1) of the
Companies Act, 2013 during the year are provided in Notes forming part of Financial Statements.
Further there were no contracts or arrangements entered with the Company''s Promoters,
Directors, Management or their relatives which could have had a potential conflict with the
interests of the company.
11. EXPLANATIONS OR COMMENTS ON QUALIFICATIONS, RESERVATIONS OR ADVERSE
REMARKS OR DISCLAIMERS MADE BY THE AUDITORS AND THE SECRETARIAL AUDITORS
IN THEIR REPORTS
Observations of Statutory Auditors and Secretarial Auditors are self-explanatory and do not call
for any further comments.
i. Statutory Auditors:
During the year under review, there were no audit qualifications made by the Auditors in their
Report on the Company''s financial statements. The Company continues to adopt best accounting
practices to ensure a regime of un-qualified financial statements.
ii. Secretarial Auditors:
Secretarial Audit is conducted according to the provisions of Section 204 of the Companies Act,
2013 read with Rule 9 of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014. Secretarial Audit Report contains following qualifications:
As per Regulation 31(2) of Listing Obligation and Disclosure requirements, Regulations 2015,
100% percent of shareholding of Promoter is not in Dematerialized Form;
Directors Comment: The Promoter shareholding will be converted in to Demat at the earliest as
per regulation 31(2) of SEBI (Listing Obligation and Disclosure requirements) Regulations,
2015.
The Secretarial Audit Report submitted by Secretarial Auditor is enclosed as a part of this report
as Annexure- A.
12. REMUNERATION RATIO OF THE DIRECTORS/ KEY MANAGERIAL PERSONNEL
(KMP)/EMPLOYEES
The information required pursuant to Section 197 read with Rule 5 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014 in respect of Directors
and Key Managerial Personnel of the Company is furnished in Annexure B to this report.
13. COMPANY''S POLICY RELATING TO DIRECTORS'' APPOINTMENT AND
REMUNERATION
The remuneration policy of the company has been framed by the Nomination and Remuneration
Committee of the Company. The Company''s Policy relating to appointment of Directors,
payment of remuneration, Directors'' qualifications, positive attributes, independence of
Directors Etc. pursuant to Section 178(3) of the Companies Act, 2013 is as follows:
The Company considers human resources as its invaluable assets. The policy of the company on
nomination and remuneration of Directors, Key Managerial Personnel (KMPs) and other
employees has been formulated in terms of Section 178, Section 197 and other applicable
provisions of the Companies Act, 2013 and the listing agreement in order to pay equitable
remuneration to the Directors, KMPs and employees of the Company and to harmonize the
aspirations of human resources consistent with the goals of the Company.
Remuneration payable to Directors of the Company are as per the limits as contained in the
provisions of Section 197 read with Schedule V of the Companies Act, 2013.
The Remuneration Policy of the Company stipulates the criteria for determining qualifications,
competencies, positive attributes and independence for appointment of a Director (Executive
/Non-Executive) and provides the Board, information about the matters relating to the
remuneration of the Directors, Key Managerial Personnel and other employees. This includes,
reviewing and approving corporate goals and objectives relevant to the compensation of the
Directors, Key Managerial Personnel and other employees and evaluating the performance of
Directors, Key Managerial Personnel and other employees in light of those goals and objectives.
The Remuneration Policy of the company stipulates that:
a) The composition of remuneration is such that it is reasonable and sufficient to attract, retain and
motivate the directors of the quality required to run the company successfully.
b) There is proper relationship between remuneration and performance.
c) Remuneration to Directors, Key Managerial Personnel and Senior Management involves a
balance between fixed and incentive pay reflecting short- and long-term performance objective
appropriate to the working of the company and its goals.
14. EXTRACT OF ANNUAL RETURN
The Annual Return of the Company referred to in Section 92(3) of the Companies Act, 2013 has
been placed on the website of the Company www.jaipurhospital.co.in.
15. DETAILS OF BOARD MEETINGS CONDUCTED DURING THE YEAR
During the Financial Year 2024-25, 6 meetings of the Board of Directors were held as per Section
173 of Companies Act, 2013 details of which are summarized below. The provisions of
Companies Act, 2013 were adhered to while considering the time gap between two meetings.
|
Date of Meeting |
|
30th May, 2024 |
|
25th July, 2024 |
|
13th August, 2024 |
|
06th September, 2024 |
|
14th November, 2024 |
|
10th January, 2025 |
16. DIRECTOR''S RESPONSIBILITY STATEMENT
In accordance with the provisions of Section 134(5) of the Companies Act, 2013 the Board hereby
submits its responsibility statement and confirms that: -
(a) In the preparation of the annual accounts for the year ended 31 st March, 2025, the applicable
Indian Accounting Standards had been followed along with proper explanation relating to
material departures;
(b) The Directors have selected such accounting policies and applied them consistently and
made judgments and estimates that are reasonable and prudent so as to give a true and fair
view of the state of affairs of the company at the end of the financial year and of the profit and
loss of the company for that period;
(c) The Directors have taken proper and sufficient care for the maintenance of adequate
accounting records in accordance with the provisions of this Act for safeguarding the assets
of the company and for preventing and detecting fraud and other irregularities;
(d) The Directors have prepared the annual accounts on a going concern basis;
(e) The Directors have laid down internal financial controls to be followed by the company that
are adequate and operating effectively; and
(f) The Directors have devised proper systems to ensure compliance with the provisions of all
applicable laws and these are adequate and are operating effectively.
17. SUBSIDIARIES AND JOINT VENTURES COMPANIES
The Company does not have any Subsidiary and Joint venture Companies.
18. DEPOSITS
The Company has neither accepted nor renewed any deposits covered under the provisions of section
73 and Chapter V of the Companies Act, 2013 read with the Companies (Acceptance of Deposits)
Rules, 2014 during the year.
19. DIRECTORS AND KEY MANAGERIAL PERSONNEL (KMP)
The composition of Board is in accordance with the requirements set forth by Section 149 of
Companies Act, 2013. The Directors possess experience in various fields that encompass Medical
and Health, Law, Banking, Accounting and Finance. The composition of Board of Directors consists of
Directors which is a perfect combination of Executive, Independent and Non Executive Directors. The
changes in the constitution of Board / KMPs during the financial year and the status of Board of
Directors/ KMPs as on 31.03.2025 are as follows:
|
Sr. No |
Name |
Designation |
Category |
Date of |
Date of |
|
1. |
Karan Sharma |
Director |
Non¬ Executive |
01/04/2007 |
N.A. |
|
2. |
Shailendra |
Managing Director |
Executive |
16/11/1989 |
N.A. |
|
3. |
Maya Sharma |
Director |
Non¬ Executive |
18/09/2015 |
N.A. |
|
4. |
Vimal Kumar |
Chief Financial |
N.A. |
14/08/2014 |
N.A |
|
5. |
Bhawana Sharma |
Company Secretary |
N.A. |
07/09/2022 |
N.A. |
|
6. |
Pushpendra |
Independent Director |
Non¬ Executive Independent |
04/09/2023 |
N.A. |
|
7. |
Rajeev Kumar |
Independent Director |
Non¬ Executive Independent |
04/09/2023 |
N.A. |
|
8. |
Mr. Pawan Shorey |
Independent Director |
Non¬ Executive Independent |
30/05/2024 |
N.A. |
|
9. |
Mr. Srikant |
Independent Director |
Non¬ Executive Independent |
30/05/2024 |
N.A. |
|
10. |
Smt. Radhika |
Director |
Non¬ Executive |
30/05/2024 |
N.A. |
During the year under review Pawan Shorey (DIN: 10636955) and Srikant Vinayakrao Bulakh (DIN:
10637125) were appointed as Non Executive, Independent Directors and Radhika Sathe (DIN:10645753)
was appointed as Non Executive Director.
Dr. Shailendra Kumar Sharma (DIN: 00432070) was re-appointed as the Managing Director of the
Company with effect from 07.09.2022. Based on the recommendations of the Nomination and
Remuneration Committee, the Board of Directors at its meeting held on 06.09.2025, approved the re¬
appointment of Dr. Shailendra Kumar Sharma (DIN: 00432070) as Managing Director for a further period
of three years with effect from 07.09.2025, subject to approval of the shareholders.
Hence, re-appointment and remuneration payable to Dr. Shailendra Kumar Sharma (DIN: 00432070), as
Managing Director of the Company, for a further period of three (3) years, with effect from 07.09.2025 to
06.09.2028, is recommended by the Board of Directors of the Company for approval of the Members of
the Company at the forthcoming Annual General Meeting.
Dr. Pushpendra Prasad Garg (DIN: 10304570) was appointed as the Non Executive, Independent
Director of the Company with effect from 04.09.2023. The Board of Directors at its meeting held on
06.09.2025, approved the continuation of appointment of Dr. Pushpendra Prasad Garg (DIN: 10304570)
as Non Executive, Independent Director till 03.09.2028 on which date he attains 75 years of age, subject
to approval of the shareholders.
Hence, continuation of appointment of Dr. Pushpendra Prasad Garg (DIN: 10304570) as Non Executive,
Independent Director till 03.09.2028 on which date he attains 75 years of age, is recommended by the
Board of Directors of the Company for approval of the Members of the Company at the forthcoming
Annual General Meeting
None of the Directors of the Company is disqualified from being appointed as Directors as on 31.03.2025.
20. DECLARATION BY INDEPENDENT DIRECTORS
The Independent Directors have submitted their declaration to the Board that they fulfill all the
requirements as stipulated in Section 149(6) of the Companies Act, 2013.
21. MEETING OF INDEPENDENT DIRECTORS:
As stipulated in the Code of Conduct for Independent Directors under the Act and Listing Regulations, a
separate Meeting of Independent Directors of the Company was held on 14th February, 2025 to review
the performance of Non-Independent Directors (including the Chairman) and the Board as a whole. The
Independent Directors also assessed the quality, quantity and timeliness of flow of information between
the Company Management and the Board, which is necessary to effectively and reasonably perform and
discharge their duties. The meeting decided on the process of evaluation of the Board and Audit
Committee. It designed the questionnaire on limited parameters and completed the evaluation of the
Board by Non-Executive Directors and of the Audit committee by other members of the Board. The same
was compiled by Independent authority and informed to the members.
22. FAMILIARISATION PROGRAMME FOR INDEPENDENT DIRECTORS:
The familiarization programme aims to provide Independent Directors with the Industry scenario, the
socio-economic environment in which the Company operates, the business model, the operational and
financial performance of the Company, significant developments so as to enable them to take well
informed decisions in a timely manner. The familiarization programme also seeks to update the Directors
on the roles, responsibilities, rights and duties under the Act and other statutes. The policy on Company''s
familiarization programme for Independent Directors is posted on Company''s website at
www.jaipurhospital.co.in
23. AUDITORS: -
23.1 Statutory Auditors
M/s Gopal Sharma & Co., Chartered Accountants, Jaipur (Firm Registration No. 002803C) were appointed
as Statutory Auditors of the Company in the 34th Annual General Meeting for a term of 5 years, i.e., till
the conclusion of Annual General Meeting to be held for the financial year 2027-28.
The Auditor''s Report for the financial year 2024-25 on the Financial Statements of the Company is
attached as a part of this Annual Report.
M/s Gopal Sharma & Co., Chartered Accountants., have confirmed their eligibility and qualification
required under Section 139, 141 and other applicable provisions of the Companies Act, 2013 and Rules
made there under (including any statutory modification(s) or re-enactment(s) thereof for the time being
in force).
23.2 Cost Auditors
Pursuant to Section 148 of the Companies Act, 2013 read with rules made there under the
maintenance of cost audit records is not applicable to the company.
23.3 Secretarial Auditors
The Company has appointed Secretarial Auditors to conduct the secretarial audit for the Financial
Year ended 31.03.2025 according to the provisions of section 204 of the Companies Act, 2013 read
with Rule 9 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014.
Furthermore, appointment of M/s. HSPN and Associates LLP, Practicing Company Secretaries, as the
Secretarial Auditors of the Company for a term of five (5) consecutive financial years commencing
from the financial year 2025-26 to 2029-30, to conduct secretarial audit as prescribed under Section
204 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 9 of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is recommended
by the Board of Directors of the Company for approval of the Members of the Company at the
forthcoming Annual General Meeting.
24. COMMITTEES OF THE BOARD
Details of the Committees of the Board of Directors of the Company as on 06.09.2025 is as under:-
a) Audit Committee
The constitution of audit committee is in confirmation with the requirements of Section 177 of the
Companies Act, 2013. As on 06.09.2025, the Audit Committee of the Company consists of 6 Directors,
out of which 4 Directors are Independent (Details of the same are summarized below). The
Committee is chaired by CA Rajeev Kumar, an Independent Director. All the members of the audit
committee are financially literate and are able to read and understand the financial statements.
|
Sr. No. |
Name of Members of |
Nature of Directorship |
Designation |
|
1. |
CA Rajeev Kumar |
Independent Director |
Chairman |
|
2. |
Maya Sharma |
Non-Executive Director |
Member |
|
3. |
Radhika Sathe |
Non-Executive Director |
Member |
|
4. |
Dr Pushpendra Prasad |
Independent Director |
Member |
|
5. |
Pawan Shorey |
Independent Director |
Member |
|
6. |
Srikant Vinayakrao |
Independent Director |
Member |
b) Nomination & Remuneration Committee
The constitution of Nomination & Remuneration Committee is in confirmation with the requirements
of Section 178 of the Companies Act, 2013. As on 06.09.2025, the Nomination & Remuneration
Committee of the Company consists of 6 Directors, out of which 4 directors are Independent (Details
of the same are summarized below). The Committee is chaired by CA Rajeev Kumar, an Independent
Director.
|
Sr. No. |
Name of Members of |
Nature of Directorship |
Designation |
|
1. |
CA Rajeev Kumar |
Independent Director |
Chairman |
|
2. |
Maya Sharma |
Non-Executive Director |
Member |
|
3. |
Radhika Sathe |
Non-Executive Director |
Member |
|
4. |
Dr Pushpendra Prasad |
Independent Director |
Member |
|
5. |
Pawan Shorey |
Independent Director |
Member |
|
6. |
Srikant Vinayakrao |
Independent Director |
Member |
c) Stakeholders Relationship Committee
The constitution of Stakeholders Relationship Committee is in confirmation with the requirements of
Section 178 of the Companies Act, 2013. As on 06.09.2025, the Stakeholders Relationship Committee
of the Company consists of 6 Directors (Details of the same are summarized below). The Committee is
chaired by Dr. Karan Sharma, a Non-Executive Director.
|
Sr. No. |
Name of Members of |
Nature of Directorship |
Designation |
|
1. |
Karan Sharma |
Non-Executive Director |
Chairman |
|
2. |
Radhika Sathe |
Non-Executive Director |
Member |
|
3. |
Dr Pushpendra Prasad |
Independent Director |
Member |
|
4. |
CA Rajeev Kumar |
Independent Director |
Member |
|
5. |
Pawan Shorey |
Independent Director |
Member |
|
6. |
Srikant Vinayakrao |
Independent Director |
Member |
d) Share Transfer Committee
The Share Transfer Committee has been constituted to oversee the matters related with transfer of
shares of the company so as to avoid delay in Share Transfer Process and to expeditiously resolve the
issues related with share transfers. As on 06.09.2025, the Share Transfer Committee of the Company
consists of 7 Directors (Details of the same are summarized below).
The Committee is chaired by Dr. Karan Sharma, a Non-Executive Director.
|
Sr. No. |
Name of Members of |
Nature of Directorship |
Designation |
|
1. |
Karan Sharma |
Non-Executive Director |
Chairman |
|
2. |
Radhika Sathe |
Non-Executive Director |
Member |
|
3. |
Shailendra Kumar Sharma |
Managing Director |
Member |
|
4. |
Dr Pushpendra Prasad |
Independent Director |
Member |
|
5. |
CA Rajeev Kumar |
Independent Director |
Member |
|
6. |
Pawan Shorey |
Independent Director |
Member |
|
7. |
Srikant Vinayakrao |
Independent Director |
Member |
25. VIGIL MECHANISM
Pursuant to the provisions of Section 177(9) & (10) of the Companies Act, 2013 the Company has
established a vigil mechanism for directors and employees to report genuine concerns. The Vigil
Mechanism provides adequate safeguards against victimization of employees and directors who
express their concerns.
The Mechanism provides direct access to the chairman of the Audit Committee. The Vigil Mechanism
Policy has been uploaded on the website of the Company at www.jaipurhospital.co.in
26. SHARES
a) BUY BACK OF SHARES
During the year under review Company has not dealt with buy back proposal.
b) SWEAT EQUITY
During the year under review the Company has not issued any Sweat Equity Shares.
c) BONUS SHARES
During the year under review no Bonus Shares were issued.
d) EMPLOYEES STOCK OPTION PLAN
The Company has not provided any Stock Option Scheme to the employees during the year.
e) SHARE CAPITAL
The paid up Equity Share Capital as on March 31, 2025 was Rs. 3, 28, 38,000. During the
year under review, the Company has not issued shares with differential voting rights.
27. MANAGEMENT DISCUSSION AND ANALYSIS REPORT
As required under Regulation 34 (1) (e) of SEBI (Listing Obligations and Disclosure Requirement)
Regulations, 2015, Management Discussion and Analysis report is enclosed to this report.
28. CORPORATE GOVERNANCE REPORT
The Company does not fulfill the criteria as specified under sub regulation (2) of regulation 15 of
Chapter IV of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 ("The
Regulations, 2015â) with respect to applicability of Corporate Governance provisions mentioned in
regulations 17 to 27 and clauses (b) to (i) of sub regulation (2) of regulation 46 and paras C, D and E
of Schedule V of the Regulations, 2015. Therefore, the Corporate Governance Report pursuant to sub
regulation (3) of regulation 34 and Schedule V of the Regulations, 2015 need not be attached to this
report.
29. ANNUAL EVALUATION OF THE PERFORMANCE OF THE BOARD AND COMMITTEES
The performance of the Board of Directors and Committees of the company are evaluated on the basis
of fulfillment of short term and long-term objectives of the company. Besides this, other qualitative
and quantitative factors are also considered the basis of evaluation of the Board of Directors and
Committees.
30. ADEQUACY OF INTERNAL FINANCIAL CONTROLS
The company has adequate Internal Financial Controls with reference to the Financial Statements.
Details of the same are provided in Management Discussion and Analysis Report.
The Company has adequate system of internal control to safeguard and protect from loss,
unauthorized use or disposition of its assets.
All the transactions are properly authorized, recorded and reported to the Management. The
Company is following all the applicable Indian Accounting Standards for properly maintaining the
books of accounts and reporting financial statements.
31. CHANGE IN NATURE OF BUSINESS
There is no change in the nature of business of the company during the financial year.
32. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS
There are no significant material orders passed by the Regulators / Courts which would impact the
going concern status of the Company and its future operations.
The BSE (Bombay Stock Exchange) had suspended for trading in the equity shares of the Company
due to penal reason.
The company had also made an application for revocation of suspension of trading in equity shares of
the company. Accordingly, the company has been granted In Principle approval for revocation of
suspension in trading of securities of company on April 30 2024, and the Company has also received
post approval for revocation of suspension in trading of equity shares which was revoked and trading
in shares was started on 20th June 2024.
33. INDIAN ACCOUNTING STANDARDS
The Audited Financial Statements prepared by the Company, in accordance with the Indian
Accounting Standards (Ind AS), are provided in the Annual Report of the Company.
34. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION AND PROTECTIONFUND
(IEPF)
No amount is required to be transferred under the provisions of Section 125(2) of the Companies Act,
2013 as there was no dividend declared and paid in last years.
35. INSIDER TRADING PREVENTION CODE
Pursuant to the SEBI Insider Trading Code, the company has formulated a comprehensive policy for
prohibition of Insider Trading in Equity Shares to preserve the confidentiality and to prevent misuse
of unpublished price sensitive information. The Company Secretary has been designated as the
Compliance Officer in this regard.
36. PREVENTION OF SEXUAL HARASSMENT AT WORKPLACE
The Company has zero tolerance towards sexual harassment at the workplace and has adopted a
policy on prevention, prohibition and redressal of sexual harassment at workplace in line with the
provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal)
Act, 2013 and the Rules made thereunder. As required under law, an Internal Complaints Committee
has been constituted for reporting and conducting inquiry into the complaints made by the victim on
the harassment at the work place.
The following is a summary of Sexual Harassment Complaints received and disposed off during
the financial year 2024-25:
a. Number of Complaints pending at the beginning of the year: NIL
b. Number of Complaints of Sexual Harassment received during the year: NIL
c. Number of Complaints disposed off during the year: NA
d. Number of cases pending for more than ninety days: NIL
e. Number of workshops or awareness programme against Sexual Harassment carried out:
Five
f. Nature of action taken by the Company: NA
g. Number of Complaints pending at the end of the year: NIL
37. DEMAT SUSPENSE/UNCLAIMED SUSPENSE ACCOUNT
The disclosure requirements with respect to Demat Suspense/Unclaimed Suspense Account are not
applicable to the Company as there are no shares in the Demat Suspense/Unclaimed Suspense
Account.
38. COMPLIANCE OF SECRETARIAL STANDARDS
The Directors have devised proper systems to ensure compliance with the provisions of all applicable
Secretarial Standards and that such systems are adequate and operating effectively.
39. DISCLOSURE PURSUANT TO CLAUSE (ix) OF SUB-RULE (5) OF RULE 8 OF THE
COMPANIES (ACCOUNTS) RULES, 2014
The maintenance of cost records as specified by the Central Government under sub-section (1) of
section 148 of the Companies Act, 2013 and maintenance of Accounts and records thereunder are not
applicable to the company.
40. DISCLOSURE PURSUANT TO SUB - SECTION (12) OF SECTION 143 OF THE COMPANIES ACT,
2013 READ WITH SUB-RULE (4) OF RULE 13 OF THE COMPANIES (AUDIT AND AUDITORS)
RULES, 2014
There have been no frauds reported by Statutory Auditors under sub-section (12) of section 143 of
the Companies Act, 2013.
41. DISCLOSURE PURSUANT TO SECTION 204 & SUB - SECTION (12) OF SECTION 143 OF THE
COMPANIES ACT, 2013 READ WITH SUB-RULE (5) OF RULE 13 OF THE COMPANIES (AUDIT
AND AUDITORS) RULES, 2014
There has been no fraud reported by Secretarial Auditors under section 204 of the Companies Act,
2013.
42. LISTING ON STOCK EXCHANGE
The Company''s shares are listed at BSE Limited.
43. INSOLVENCY AND BANKRUPTCY CODE:
During the year, there was no application made or any proceeding pending under the Insolvency
and Bankruptcy Code, 2016 hence the requirement to disclose the details of application made or
proceeding pending at the end of financial year is not applicable.
44. DISCLOSURE UNDER THE MATERNITY BENEFITS ACT, 1961:
The Company is in compliance with the provisions of the Maternity Benefit Act, 1961, which
ensures maternity benefits to women employees as per applicable law.
During the financial year ended March 31, 2025, the provisions of the Act were applicable to the
Company; however, no instances arose wherein maternity benefits were availed by any woman
employee of the Company.
The Company remains committed to providing a safe, inclusive, and supportive work environment
for all employees, in line with applicable laws and best practices.
45. ACKNOWLEDGEMENT
The Board expresses their grateful thanks for the assistance and co-operation extended by Punjab
National Bank & other Banks, various departments of State & Central Government and other
Associations.
Your Directors wish to convey their gratitude and appreciation to all employees of the Company
for their valuable contribution during the year. They also wish to place on record their appreciation
to the Company''s Customers, Investors, Shareholders, Bankers, Suppliers, Distributors and other
business associates for their cooperation and support.
Last but not the least, Directors wish to place on records their deep sense of appreciation for the
devoted services of Consultant Doctors and entire Nursing & Para-medical Staff at all levels of the
Company for its growth.
BY THE ORDER OF THE BOARD
Sd/- Sd/-
(Maya Sharma) (Shailendra Kumar Sharma)
Jaipur
September 06, 2025 DIRECTOR MANAGING DIRECTOR
DIN 00432496 DIN 00432070
Mar 31, 2024
Your Directors have pleasure in submitting their Thirty Fifth Annual Report on the business and
operations of your Company together with the Audited Financial Statements for the year ended 31st
March, 2024.
1. FINANCIAL SUMMARY / HIGHLIGHTS
(Rs. in Lakhs)
|
For the vear er |
ded on |
|
|
2023-2024 |
2022-2023 |
|
|
Revenue from Operations & Other Income |
2,383.00 |
2078.98 |
|
Profit before Interest, Depreciation & Tax |
343.10 |
336.42 |
|
Less : Interest |
94.69 |
118.12 |
|
Operating Profit |
248.41 |
218.30 |
|
Less: Depreciation |
148.04 |
139.02 |
|
Net Profit before Tax |
100.37 |
79.28 |
|
Add/(Less): Tax Expense |
||
|
Current Tax |
15.99 |
- |
|
Deferred Tax |
4.64 |
(4.12) |
|
Adjustment of taxes of earlier years |
13.44 |
- |
|
Net Profit After Tax |
66.30 |
83.40 |
|
Add: Other Comprehensive Income |
0.00 |
15.54 |
|
Less: Income Tax relating to Other Comprehensive Income |
0.00 |
1.61 |
|
Add: Surplus brought forward from Previous Year |
641.19 |
543.86 |
|
Surplus carried forward to Balance Sheet |
707.49 |
641.19 |
|
Earnings Per Share (Basic & Diluted) |
2.02 |
2.96 |
2. REVIEW OF BUSINESS OPERATIONS AND FUTURE PROSPECTS
The Company''s Total Income i.e. Revenue from Operations and Other Income are Rs. 2,383.00
Lakhs and the profit after tax (including Other Comprehensive Income) is Rs. 66.30 Lakhs during
the current year.
Further your Company has been continuously making efforts to enhance the operations and also
trying to hold its grip over upcoming opportunities in Medical & Health Industry.
3. DIVIDEND
Your Directors have considered it financially prudent in the long-term interests of the Company
to reinvest the profits into the business to build a strong reserve base and grow the business of
the Company. Further, in view of marginal funds, the Board of Directors doesn''t recommended
payment of dividend for the year under review.
4. TRANSFER TO RESERVES
No amount has been transferred to General Reserve during the year. The company carries
reserves of Rs. 707.49 Lakhs under the head âOther Equityâ at the end of the financial year 2023¬
24.
5. SIGNIFICANT MATERIAL CHANGES AFTER BALANCE SHEET DATE AFFECTING FINANCIAL
POSITION
There are no changes and commitments affecting the financial position of the company which have
occurred between the date of Balance Sheet i.e. 31.03.2024 and the date of this report.
6. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS
AND OUTGO
Details pertaining to Conservation of Energy and Technology Absorption as required under
Section 134 (3) (m) of the Companies Act, 2013 read with Rule 8 of the Companies (Accounts)
Rules, 2014 are as follows: -
(A) Conservation of Energy: The operations of the company are not energy intensive. We regularly
evaluate and use new energy efficient technologies and make necessary investment in energy
saving equipments to make our infrastructure more energy-efficient. The company is
continuously striving to conserve the energy at its all levels.
(B) Technology Absorption: Your Company strives for latest technology for its processes and also
strives to achieve full technology absorption.
There were no foreign exchange earnings and outgo during the financial year.
7. DEVELOPMENT AND IMPLEMENTATION OF RISK MANAGEMENT POLICY OF THE COMPANY
The Risk Management of the Company is overseen by the Board of Directors at various levels
and the policy of the Company on Risk Management is provided in this Annual Report in
Management Discussion and Analysis Report.
8. CORPORATE SOCIAL RESPONSIBILITIES (CSR)
The Company does not meet the criteria of Section 135 of Companies Act, 2013 read with the
Companies (Corporate Social Responsibility Policy) Rules, 2014. The Company has not developed
and implemented any Corporate Social Responsibility policy as the said provisions are not
applicable to the Company.
9. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE UNDER SECTION 186 OF
THE COMPANIES ACT, 2013
Details of loans, investments and guarantees covered under the provisions of Section 186 of
Companies Act 2013 are given in the Notes forming part of Financial Statements.
10. PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES
All related party transactions that were entered into during the financial year were on an arm''s
length basis and were in the ordinary course of business (refer Notes forming part of Financial
Statements).
The details forming part of the Related Parties Transactions under Section 188(1) of the
Companies Act, 2013 during the year are provided in Notes forming part of Financial Statements.
Further there were no contracts or arrangements entered with the Company''s Promoters,
Directors, Management or their relatives which could have had a potential conflict with the
interests of the company.
11. EXPLANATIONS OR COMMENTS ON QUALIFICATIONS, RESERVATIONS OR ADVERSE
REMARKS OR DISCLAIMERS MADE BY THE AUDITORS AND THE SECRETARIAL AUDITORS
IN THEIR REPORTS
Observations of Statutory Auditors and Secretarial Auditors are self-explanatory and do not call
for any further comments.
i. Statutory Auditors:
During the year under review, there were no audit qualifications made by the Auditors in their
Report on the Company''s financial statements. The Company continues to adopt best accounting
practices to ensure a regime of un-qualified financial statements.
ii. Secretarial Auditors:
Secretarial Audit is conducted according to the provisions of Section 204 of the Companies Act,
2013 read with Rule 9 of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014. There were no adverse comments, qualifications or reservations or
adverse remarks in the Secretarial Audit Report.
The Secretarial Audit Report submitted by Secretarial Auditor is enclosed as a part of this report
as Annexure- A.
12. REMUNERATION RATIO OF THE DIRECTORS/ KEY MANAGERIAL PERSONNEL
(KMP)/EMPLOYEES
The information required pursuant to Section 197 read with Rule 5 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014 in respect of Directors
and Key Managerial Personnel of the Company is furnished in Annexure B to this report.
13. COMPANY''S POLICY RELATING TO DIRECTORS'' APPOINTMENT AND
REMUNERATION
The remuneration policy of the company has been framed by the Nomination and Remuneration
Committee of the Company. The Company''s Policy relating to appointment of Directors,
payment of remuneration, Directors'' qualifications, positive attributes, independence of
Directors Etc. pursuant to Section 178(3) of the Companies Act, 2013 is as follows:
The Company considers human resources as its invaluable assets. The policy of the company on
nomination and remuneration of Directors, Key Managerial Personnel (KMPs) and other
employees has been formulated in terms of Section 178, Section 197 and other applicable
provisions of the Companies Act, 2013 and the listing agreement in order to pay equitable
remuneration to the Directors, KMPs and employees of the Company and to harmonize the
aspirations of human resources consistent with the goals of the Company.
Remuneration payable to Directors of the Company are as per the limits as contained in the
provisions of Section 197 read with Schedule V of the Companies Act, 2013.
The Remuneration Policy of the Company stipulates the criteria for determining qualifications,
competencies, positive attributes and independence for appointment of a Director (Executive
/Non-Executive) and provides the Board, information about the matters relating to the
remuneration of the Directors, Key Managerial Personnel and other employees. This includes,
reviewing and approving corporate goals and objectives relevant to the compensation of the
Directors, Key Managerial Personnel and other employees and evaluating the performance of
Directors, Key Managerial Personnel and other employees in light of those goals and objectives.
The Remuneration Policy of the company stipulates that:
a) The composition of remuneration is such that it is reasonable and sufficient to attract, retain and
motivate the directors of the quality required to run the company successfully.
b) There is proper relationship between remuneration and performance.
c) Remuneration to Directors, Key Managerial Personnel and Senior Management involves a
balance between fixed and incentive pay reflecting short- and long-term performance objective
appropriate to the working of the company and its goals.
14. EXTRACT OF ANNUAL RETURN
The Annual Return of the Company referred to in Section 92(3) of the Companies Act, 2013 has
been placed on the website of the Company www.jaipurhospital.co.in.
15. DETAILS OF BOARD MEETINGS CONDUCTED DURING THE YEAR
During the Financial Year 2023-24, 6 meetings of the Board of Directors were held as per Section
173 of Companies Act, 2013 details of which are summarized below. The provisions of
Companies Act, 2013 were adhered to while considering the time gap between two meetings.
|
Date of Meeting |
|
30th May, 2023 |
|
10th August, 2023 |
|
04th September, 2023 |
|
18th September, 2023 |
|
06 th November, 2023 |
|
10th February, 2024 |
16. DIRECTOR''S RESPONSIBILITY STATEMENT
In accordance with the provisions of Section 134(5) of the Companies Act, 2013 the Board hereby
submits its responsibility statement and confirms that: -
(a) In the preparation of the annual accounts for the year ended 31 51 March, 2024, the applicable
Indian Accounting Standards had been followed along with proper explanation relating to
material departures;
(b) The Directors have selected such accounting policies and applied them consistently and
made judgments and estimates that are reasonable and prudent so as to give a true and fair
view of the state of affairs of the company at the end of the financial year and of the profit and
loss of the company for that period;
(c) The Directors have taken proper and sufficient care for the maintenance of adequate
accounting records in accordance with the provisions of this Act for safeguarding the assets
of the company and for preventing and detecting fraud and other irregularities;
(d) The Directors have prepared the annual accounts on a going concern basis;
(e) The Directors have laid down internal financial controls to be followed by the company that
are adequate and operating effectively; and
(f) The Directors have devised proper systems to ensure compliance with the provisions of all
applicable laws and these are adequate and are operating effectively.
17. SUBSIDIARIES AND JOINT VENTURES COMPANIES
The Company does not have any Subsidiary and Joint venture Companies.
18. DEPOSITS
The Company has neither accepted nor renewed any deposits covered under the provisions of section
73 and Chapter V of the Companies Act, 2013 read with the Companies (Acceptance of Deposits)
Rules, 2014 during the year.
19. DIRECTORS AND KEY MANAGERIAL PERSONNEL (KMP)
The composition of Board is in accordance with the requirements set forth by Section 149 of
Companies Act, 2013. The Directors possess experience in various fields that encompass Medical
and Health, Law, Banking, Accounting and Finance. The composition of Board of Directors consists of
Directors which is a perfect combination of Executive, Independent and Non Executive Directors. The
changes in the constitution of Board / KMPs during the financial year and the status of Board of
Directors/ KMPs as on 31.03.2024 are as follows:
|
Sr. No |
Name |
Designation |
Category |
Date of |
Date of |
|
1. |
Karan Sharma |
Director |
Non¬ Executive |
01/04/2007 |
N.A. |
|
2. |
Shailendra |
Managing Director |
Executive |
16/11/1989 |
N.A. |
|
3. |
Maya Sharma |
Director |
Non¬ Executive |
18/09/2015 |
N.A. |
|
4. |
Subhash Chand |
Independent Director |
Non¬ Executive Independent |
18/09/2015 |
18/09/2023 |
|
5. |
Vimal Kumar |
Chief Financial |
N.A. |
14/08/2014 |
N.A |
|
6. |
Bhawana Sharma |
Company Secretary |
N.A. |
07/09/2022 |
N.A. |
|
7. |
Pushpendra |
Independent Director |
Non¬ Executive Independent |
04/09/2023 |
N.A. |
|
8. |
Rajeev Kumar |
Independent Director |
Non¬ Executive Independent |
04/09/2023 |
N.A. |
|
Changes between 31.03.2024 & date of signing this report |
|||||
|
1. |
Mr. Pawan Shorey |
Independent Director |
Non¬ Executive |
30/05/2024 |
N.A. |
|
Independent |
|||||
|
2. |
Mr. Srikant |
Independent Director |
Non¬ Executive Independent |
30/05/2024 |
N.A. |
|
3. |
Smt. Radhika |
Director |
Non¬ Executive |
30/05/2024 |
N.A. |
None of the Directors of the Company is disqualified from being appointed as Directors.
20. DECLARATION BY INDEPENDENT DIRECTORS
The Independent Directors have submitted their declaration to the Board that they fulfill all the
requirements as stipulated in Section 149(6) of the Companies Act, 2013.
21. AUDITORS: -
21.1 Statutory Auditors
M/s Gopal Sharma & Co., Chartered Accountants, Jaipur (Firm Registration No. 002803C) were appointed
as Statutory Auditors of the Company in the 34th Annual General Meeting for a term of 5 years, i.e., till
the conclusion of Annual General Meeting to be held for the financial year 2027-28.
The Auditor''s Report for the financial year 2023-24 on the Financial Statements of the Company is
attached as a part of this Annual Report.
M/s Gopal Sharma & Co., Chartered Accountants., have confirmed their eligibility and qualification
required under Section 139, 141 and other applicable provisions of the Companies Act, 2013 and Rules
made there under (including any statutory modification(s) or re-enactment(s) thereof for the time being
in force).
21.2 Cost Auditors
Pursuant to Section 148 of the Companies Act, 2013 read with rules made there under the
maintenance of cost audit records is not applicable to the company.
21.3 Secretarial Auditors
The Company has appointed Secretarial Auditors to conduct the secretarial audit for the Financial
Year ended 31.03.2024 according to the provisions of section 204 of the Companies Act, 2013 read
with Rule 9 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014.
22. COMMITTEES OF THE BOARD
Details of the Committees of the Board of Directors of the Company as on 06.09.2024 is as under:-
a) Audit Committee
The constitution of audit committee is in confirmation with the requirements of Section 177 of the
Companies Act, 2013. As on 06.09.2024, the Audit Committee of the Company consists of 6 Directors,
out of which 4 Directors are Independent (Details of the same are summarized below). The
Committee is chaired by CA Rajeev Kumar, an Independent Director. All the members of the audit
committee are financially literate and are able to read and understand the financial statements.
|
Sr. No. |
Name of Members of |
Nature of Directorship |
Designation |
|
1. |
CA Rajeev Kumar |
Independent Director |
Chairman |
|
2. |
Maya Sharma |
Non-Executive Director |
Member |
|
3. |
Radhika Sathe |
Non-Executive Director |
Member |
|
4. |
Dr Pushpendra Prasad |
Independent Director |
Member |
|
5. |
Pawan Shorey |
Independent Director |
Member |
|
6. |
Srikant Vinayakrao |
Independent Director |
Member |
b) Nomination & Remuneration Committee
The constitution of Nomination & Remuneration Committee is in confirmation with the requirements
of Section 178 of the Companies Act, 2013. As on 06.09.2024, the Nomination & Remuneration
Committee of the Company consists of 6 Directors, out of which 4 directors are Independent (Details
of the same are summarized below). The Committee is chaired by CA Rajeev Kumar, an Independent
Director.
|
Sr. No. |
Name of Members of |
Nature of Directorship |
Designation |
|
1. |
CA Rajeev Kumar |
Independent Director |
Chairman |
|
2. |
Maya Sharma |
Non-Executive Director |
Member |
|
3. |
Radhika Sathe |
Non-Executive Director |
Member |
|
4. |
Dr Pushpendra Prasad |
Independent Director |
Member |
|
5. |
Pawan Shorey |
Independent Director |
Member |
|
6. |
Srikant Vinayakrao |
Independent Director |
Member |
c) Stakeholders Relationship Committee
The constitution of Stakeholders Relationship Committee is in confirmation with the requirements of
Section 178 of the Companies Act, 2013. As on 06.09.2024, the Stakeholders Relationship Committee
of the Company consists of 6 Directors (Details of the same are summarized below). The Committee is
chaired by Dr. Karan Sharma, a Non-Executive Director.
|
Sr. No. |
Name of Members of |
Nature of Directorship |
Designation |
|
1. |
Karan Sharma |
Non-Executive Director |
Chairman |
|
2. |
Radhika Sathe |
Non-Executive Director |
Member |
|
3. |
Dr Pushpendra Prasad |
Independent Director |
Member |
|
4. |
CA Rajeev Kumar |
Independent Director |
Member |
|
5. |
Pawan Shorey |
Independent Director |
Member |
|
6. |
Srikant Vinayakrao |
Independent Director |
Member |
d) Share Transfer Committee
The Share Transfer Committee has been constituted to oversee the matters related with transfer of
shares of the company so as to avoid delay in Share Transfer Process and to expeditiously resolve the
issues related with share transfers. As on 06.09.2024, the Share Transfer Committee of the Company
consists of 7 Directors (Details of the same are summarized below).
The Committee is chaired by Dr. Karan Sharma, a Non-Executive Director.
|
Sr. No. |
Name of Members of |
Nature of Directorship |
Designation |
|
1. |
Karan Sharma |
Non-Executive Director |
Chairman |
|
2. |
Radhika Sathe |
Non-Executive Director |
Member |
|
3. |
Shailendra Kumar Sharma |
Managing Director |
Member |
|
4. |
Dr Pushpendra Prasad |
Independent Director |
Member |
|
5. |
CA Rajeev Kumar |
Independent Director |
Member |
|
6. |
Pawan Shorey |
Independent Director |
Member |
|
7. |
Srikant Vinayakrao |
Independent Director |
Member |
23. VIGIL MECHANISM
Pursuant to the provisions of Section 177(9) & (10) of the Companies Act, 2013 the Company has
established a vigil mechanism for directors and employees to report genuine concerns. The Vigil
Mechanism provides adequate safeguards against victimization of employees and directors who
express their concerns.
The Mechanism provides direct access to the chairman of the Audit Committee. The Vigil Mechanism
Policy has been uploaded on the website of the Company at www.jaipurhospital.co.in
24. SHARES
a) BUY BACK OF SHARES
During the year under review Company has not dealt with buy back proposal.
b) SWEAT EQUITY
During the year under review the Company has not issued any Sweat Equity Shares.
c) BONUS SHARES
During the year under review no Bonus Shares were issued.
d) EMPLOYEES STOCK OPTION PLAN
The Company has not provided any Stock Option Scheme to the employees during the year.
e) SHARE CAPITAL
The paid up Equity Share Capital as on March 31, 2024 was Rs. 3, 28, 38,000. During the
year under review, the Company has not issued shares with differential voting rights.
25. MANAGEMENT DISCUSSION AND ANALYSIS REPORT
As required under Regulation 34 (1) (e) of SEBI (Listing Obligations and Disclosure Requirement)
Regulations, 2015, Management Discussion and Analysis report is enclosed to this report.
26. CORPORATE GOVERNANCE REPORT
The Company does not fulfill the criteria as specified under sub regulation (2) of regulation 15 of
Chapter IV of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 (âThe
Regulations, 2015â) with respect to applicability of Corporate Governance provisions mentioned in
regulations 17 to 27 and clauses (b) to (i) of sub regulation (2) of regulation 46 and paras C, D and E
of Schedule V of the Regulations, 2015. Therefore, the Corporate Governance Report pursuant to sub
regulation (3) of regulation 34 and Schedule V of the Regulations, 2015 need not be attached to this
report.
27. ANNUAL EVALUATION OF THE PERFORMANCE OF THE BOARD AND COMMITTEES
The performance of the Board of Directors and Committees of the company are evaluated on the basis
of fulfillment of short term and long-term objectives of the company. Besides this, other qualitative
and quantitative factors are also considered the basis of evaluation of the Board of Directors and
Committees.
28. ADEQUACY OF INTERNAL FINANCIAL CONTROLS
The company has adequate Internal Financial Controls with reference to the Financial Statements.
Details of the same are provided in Management Discussion and Analysis Report.
The Company has adequate system of internal control to safeguard and protect from loss,
unauthorized use or disposition of its assets.
All the transactions are properly authorized, recorded and reported to the Management. The
Company is following all the applicable Indian Accounting Standards for properly maintaining the
books of accounts and reporting financial statements.
29. CHANGE IN NATURE OF BUSINESS
There is no change in the nature of business of the company during the financial year.
30. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS
There are no significant material orders passed by the Regulators / Courts which would impact the
going concern status of the Company and its future operations.
31. INDIAN ACCOUNTING STANDARDS
The Audited Financial Statements prepared by the Company, in accordance with the Indian
Accounting Standards (Ind AS), are provided in the Annual Report of the Company.
32. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION AND PROTECTIONFUND
(IEPF)
No amount is required to be transferred under the provisions of Section 125(2) of the Companies Act,
2013 as there was no dividend declared and paid in last years.
33. INSIDER TRADING PREVENTION CODE
Pursuant to the SEBI Insider Trading Code, the company has formulated a comprehensive policy for
prohibition of Insider Trading in Equity Shares to preserve the confidentiality and to prevent misuse
of unpublished price sensitive information. The Company Secretary has been designated as the
Compliance Officer in this regard.
34. PREVENTION OF SEXUAL HARASSMENT AT WORKPLACE
The Company has zero tolerance towards sexual harassment at the workplace and has adopted a
policy on prevention, prohibition and redressal of sexual harassment at workplace in line with the
provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal)
Act, 2013 and the Rules made thereunder. As required under law, an Internal Complaints Committee
has been constituted for reporting and conducting inquiry into the complaints made by the victim on
the harassment at the work place.
The following is a summary of Sexual Harassment Complaints received and disposed off during
the financial year 2023-24:
a. Number of Complaints pending at the beginning of the year: NIL
b. Number of Complaints of Sexual Harassment received during the year: NIL
c. Number of Complaints disposed off during the year: NA
d. Number of cases pending for more than ninety days: NIL
e. Number of workshops or awareness programme against Sexual Harassment carried out: Six
f. Nature of action taken by the Company: NA
g. Number of Complaints pending at the end of the year: NIL
35. DEMAT SUSPENSE/UNCLAIMED SUSPENSE ACCOUNT
The disclosure requirements with respect to Demat Suspense/Unclaimed Suspense Account are not
applicable to the Company as there are no shares in the Demat Suspense/Unclaimed Suspense
Account.
36. COMPLIANCE OF SECRETARIAL STANDARDS
The Directors have devised proper systems to ensure compliance with the provisions of all applicable
Secretarial Standards and that such systems are adequate and operating effectively.
37. DISCLOSURE PURSUANT TO CLAUSE (ix) OF SUB-RULE (5) OF RULE 8 OF THE
COMPANIES (ACCOUNTS) RULES, 2014
The maintenance of cost records as specified by the Central Government under sub-section (1) of
section 148 of the Companies Act, 2013 and maintenance of Accounts and records thereunder are not
applicable to the company.
38. DISCLOSURE PURSUANT TO SUB - SECTION (12) OF SECTION 143 OF THE COMPANIES ACT,
2013 READ WITH SUB-RULE (4) OF RULE 13 OF THE COMPANIES (AUDIT AND AUDITORS)
RULES, 2014
There have been no frauds reported by Statutory Auditors under sub-section (12) of section 143 of
the Companies Act, 2013.
39. DISCLOSURE PURSUANT TO SECTION 204 & SUB - SECTION (12) OF SECTION 143 OF THE
COMPANIES ACT, 2013 READ WITH SUB-RULE (5) OF RULE 13 OF THE COMPANIES (AUDIT
AND AUDITORS) RULES, 2014
There has been no fraud reported by Secretarial Auditors under section 204 of the Companies Act,
2013.
40. LISTING ON STOCK EXCHANGE
The Company''s shares are listed at BSE Limited.
41. ACKNOWLEDGEMENT
The Board expresses their grateful thanks for the assistance and co-operation extended by Punjab
National Bank & other Banks, various departments of State & Central Government and other
Associations.
Your Directors wish to convey their gratitude and appreciation to all employees of the Company for
their valuable contribution during the year. They also wish to place on record their appreciation to
the Company''s Customers, Investors, Shareholders, Bankers, Suppliers, Distributors and other
business associates for their cooperation and support.
Last but not the least, Directors wish to place on records their deep sense of appreciation for the
devoted services of Consultant Doctors and entire Nursing & Para-medical Staff at all levels of the
Company for its growth.
BY THE ORDER OF THE BOARD
Sd/- Sd/-
Jaipur (Maya Sharma) (Shailendra Kumar Sharma)
September 06, 2024 DIRECTOR MANAGING DIRECTOR
DIN 00432496 DIN 00432070
Mar 31, 2014
Dear Members,
The Directors are delighted in presenting the Twenty Fifth Annual
Report on the business and operations of your Company together with
Audited Annual Accounts and Cash Flow Statement for the year ended on
31st March, 2014.
1. FINANCIAL RESULTS
(Rs. in Lacs)
For the year ended on
2013-2014 2012-2013
Professional Receipts & Other income 1354.51 1286.71
Profit before interest, Depreciation & Tax 222.12 230.97
Less : Interest 58.62 90.50
Operating Profit 163.50 140.47
Less: Depreciation 59.88 59.67
Net Profit before Tax 103.62 80.80
Less: Provision for Taxation
Current Tax 29.67 23.77
Deferred Tax (Net) 2.35 1.65
Net Profit After Tax 71.60 55.38
Add: Profit brought forward from Previous Year 171.01 115.63
Surplus carried forward to Balance Sheet 242.61 171.01
2 REVIEW OF OPERATIONS:
In spite of the stiff competition in the medical industry affecting the
operations of your Company, your Company has performed satisfactorily
by maintaining almost same profit level of the previous year before
Interest, Depreciation and Taxes. Further your Company has been
continuously making efforts to enhance the operations and also trying
to hold its grip over upcoming opportunities in Medical & Health
Industry. Net Profit after Tax has been increased by 29.29% as compared
to the last year.
3 DIVIDEND:
In view of marginal funds, the Board of Directors doesn''t recommend
payment of dividend for the year under review.
4 DISCLOSURE OF MATERIAL CHANGES SINCE THE DATE OF BALANCE SHEET :
There is no material changes since the date of Balance Sheet regarding
(a) Disposal of a substantial part of undertaking
(b) Changes in Capital Structure of the Company
(c) Serious break down
(d) Alteration in wage structure arising out of trade union
negotiations
(e) Providing medical and health services.
5. DISCLOSURE OF COMPOSITION OF THE AUDIT COMMITTEE:
The constitution of audit committee is in confirmation with the
requirements of Section 292A of the Companies Act, 1956 and also as per
the requirements of Clause 49(II) (A) of the listing agreement. The
composition of Audit Committee has been changed on 29th May, 2014 due
to the resignation of Mr. Ashok Kumar Agarwal, being an Independent
Director of the company . Now the Audit Committee of the Company
consists of 4 Directors: Shri Ganpat Rai Sharma, Shri Subhash Chand
Jain, Shri Madhur Krishna Khaitan and Mrs. Avani Kanoi all being Non-
Executive. The Committee is now chaired by Shri Madhur Krishna Khaitan
an Independent Director. All the members of the audit committee are
financially literate and majority of them are having accounting or
related financial management expertise.
6. OUTLOOK FOR 2014-15:
The Company can look back with satisfaction at the last year
performance as being ever improving. The Company is working towards
sustaining this momentum in the current year also. During the year
under review the hospital unit re-equipped with all latest facility
with available high-tech equipments and expertise of all the
specialties and maintained high quality service and status in the line.
Your Company is running a successful Cardiac Department through JAIPUR
HEART INSTITUTE. But the vision of management does not stop here
itself. Constant exploration of new medical services, introduction of
Hi-tech equipments which will benefit the patients would certainly
drive the growth in the coming years. The Nursing College also started
M.Sc. nursing batch and only two colleges are recommended by the
Rajasthan Government to provide the masters degree in nursing and one
of them is our college.
7. ATTACHMENT OF THE COMPLIANCE CERTIFICATE OBTAINED FROM A COMPANY
SECRETARY IN PRACTICE:
Your Company has employed a whole time Company Secretary. So company
doesn''t require to obtain Compliance Certificate from a Company
Secretary in Practice.
8. FIXED DEPOSITS:
The Company has not accepted any public deposits and hence the rules
made there under are not applicable to the Company.
9. COMMENTS ON RESERVATIONS, QUALIFICATIONS OR ADVERSE REMARKS GIVEN IN
THE AUDITORS REPORT:
During the year under review, there was no audit qualification made by
the Auditor in their Report on the Company''s financial statements. The
Company continues to adopt best accounting practices to ensure a regime
of un-qualified financial statements.
10. CORPORATE GOVERNANCE:
The Company has implemented the Corporate Governance requirements.
Management Discussion and analysis and a report on compliance of
Corporate Governance are enclosed as Annexure to the Director''s Report.
11. DIRECTORS
In accordance with the provisions of the Companies Act, 2013 and the
Articles of Association, Mr. Madhur Krishan Khaitan and Mrs. Avani
Kanoi, Directors of the Company retire by rotation at the ensuing
Annual General Meeting and being eligible offer themselves for
re-appointment. During the year Mr. Ashok Kumar Agarwal, being an
Independent Director has resigned from the Directorship and the Board
of Directors duly accepted the same.
None of the Directors of the Company is disqualified for being
appointed as Directors.
12. DIRECTOR''S RESPONSIBILTY STATEMENT U/S 217(2AA):
Pursuant to Section 217(2AA) of the Companies Act, 1956, the Directors
based on the representation received from operating management, confirm
that:
(i) In the Preparation of Annual Accounts, the applicable accounting
standards had been followed along with proper explanation to the
material departures.
(ii) Directors had in selection of the accounting policies, consulted
the statutory auditors and have applied them consistently and made
judgments and estimates that are reasonable and prudent so as to give a
true and fair view of the state of affairs of the Company at the end of
the financial year and of the profit of the Company for the period.
(iii) Directors had taken proper and sufficient care, to the best of
their knowledge and ability, for the maintenance of adequate accounting
records in accordance with the provisions of the Companies Act for
safeguarding the assets of the Company and for preventing and detecting
fraud and other irregularities.
(iv) Directors had prepared the Annual Accounts on a going concern
basis.
13. CONSERVATION OF ENERGY, TECHNOLOGY, FOREIGN EXCHANGE EARNINGS AND
OUT GO:
Since the Company is engaged in medical service sector and has no
activity pertaining to manufacturing hence furnishing of details
pertaining to Conservation of Energy and Technology Absorption are not
applicable as required under Section 217 (1) (e) of the Companies Act,
1956 read with Companies (Disclosure of particulars in the Report of
Board of Directors) Rules 1988. There were no foreign exchange
earnings and outgoing during the year.
14. AUDITORS AND AUDITOR''S REPORT:
The Observation and comments given by the Auditors in their report
together with notes to Accounts are self explanatory and hence do not
call for any further comments.
The Board on the recommendation of the Audit Committee had proposed
that M/s Gopal Sharma & Co., Chartered Accountants, Jaipur be
re-appointed as the Statutory Auditors of the Company to hold office
till the conclusion of the Thirtieth Annual General Meeting of the
Company. M/s Gopal Sharma & Co., Chartered Accountants, Jaipur have
forwarded their certificate to the Company, stating that their
re-appointment, if made, will be within the limit specified in that
behalf as per Companies Act, 2013.
15. PARTICULARS OF EMPLOYEES :
The Company has not paid any remuneration attracting the provisions of
Companies (Particulars of Employees) Rules, 1975 read with Section 217
(2A) of the Companies Act, 1956. Hence no information is required to be
appended to this report in this regard.
16. REPORTS ON PROJECTION MADE IN OFFER DOCUMENTS FOR PUBLIC OR RIGHT
ISSUE BY A LISTED COMPANY :
During the year under review Company had not issued any offer document.
17. REPORT OF THE UTILIZATION OF PROCEEDS OF THE PUBLIC, RIGHT ISSUE
AND PREFERENTIAL ALLOTMENT OF SECURITIES
During the year under review Company had not come up with any public,
right and preferential allotment.
18. DISCLOSURE FOR FAILURE TO COMPLETE BUY-BACK WITHIN TIME :
During the year under review Company had not dealt with any Buy back
proposal.
19. DISCLOSURE FOR ISSUANCE OF SWEAT EQUITY SHARES :
During the year under review Company had not issued any Sweat Equity
Shares.
20. ACKNOWLEDGEMENT
The Board expresses its grateful thanks for the assistance and
co-operation extended by Punjab National Bank & other Banks, various
departments of State & Central Government and other Associations.
Your Directors wish to convey their gratitude and appreciation to all
employees of the Company for their valuable contribution during the
year. They also wish to place on record their appreciation to the
Company''s Customers, Investors, Shareholders, Bankers, Suppliers,
Distributors and other business associates for their cooperation and
support.
Last but not the least Directors wish to place on records their deep
sense of appreciation for the devoted services of Consultant Doctors
and entire Nursing Staff at all levels of the Company for its growth.
BY THE ORDER OF THE BOARD
Place : Jaipur Sd/- Sd/-
Date : 14.08.2014 (Dr. SHAILENDRA KR SHARMA) (GANPAT RAI SHARMA)
MANAGING DIRECTOR CHAIRMAN
DIN: 00432070 DIN: 00458217
Mar 31, 2013
To, The Members,
The Directors are delighted in presenting the Twenty Fourth Annual
Report on the business and operations of your Company together with
Audited Annual Accounts and Cash Flow Statement for the year ended on
31st March, 2013.
1. FINANCIAL RESULTS
(Rs.in Lacs)
For the year ended on
2012-2013 2011-2012
Professional Receipts & Other income 1286.71 1349.91
Profit before interest, Depreciation & Tax 230.97 215.22
Less: Interest 90.50 108.24
Operating Profit 140.47 106.98
Less: Depreciation 59.67 60.95
Net Profit before Tax 80.80 46.03
Less: Provision for Taxation
Current Tax 23.77 12.55
Deferred Tax (Net) 1.65 1.84
Net Profit After Tax 55.38 31.64
Add: Profit brought forward
from Previous Year 115.63 83.99
Surplus carried forward to Balance Sheet 171.01 115.63
2. REVIEW OF OPERATION:
Inspite of the stiff competition in the medical industry affecting the
operations of your Company, your Company has performed satisfactorily
by maintaining almost same profit level of the previous year before
Interest, Depreciation and Taxes. Further your Company has been
continuously making efforts to enhance the operations and also trying
to hold its grip over upcoming opportunities in Medical & Health
Industry. Net Profit after Tax has been increased by 75.03% as compared
to the last year.
3 DIVIDEND:
In view of marginal funds, the Board of Directors doesn''t recommend
payment of dividend for the year under review.
4 DISCLOSURE OF MATERIAL CHANGES SINCE THE DATE OF BALANCE SHEET :
There is no material changes since the date of Balance Sheet regarding
(a) Disposal of a substantial part of undertaking
(b) Changes in Capital Structure of the Company
(c) Serious break down
(d) Alteration in wage structure arising out of trade union
negotiations
(e) Providing medical and health services.
5. DISCLOSURE OF COMPOSITION OF THE AUDIT COMMITTEE:
The constitution of audit committee is in confirmation with the
requirements of Section 292(A) of the Companies Act, 1956 and also as
per the requirements of Clause 49(H) (A) of the listing agreement. The
Audit Committee of the Company consists of 5 Directors : Shri. Ganpat
Rai Sharma, Shri. Ashok Agarwal, Shri. Subhash Chand Jain, Shri Madhur
Krishna Khaitan and Mrs. Avani Kanoi all being Non-Executive. The
Committee is chaired by Shri. Ashok Agarwal an Independent Director.
All the members of the audit committee are financially literate and
majority of them are having accounting or related financial management
expertise.
6. OUTLOOKFOR2013-14:
The Company can look back with satisfaction at the last year
performance as being ever improving. The Company is working towards
sustaining this momentum in the current year also. During the year
under review the hospital unit re-equipped with all latest facility
with available high-tech equipments and expertise of all the
specialties and maintained high quality service and status in the line.
Your Company is running a successful Cardiac Department through JAIPUR
HEART INSTITUTE. But the vision of management does not stop here
itself. Constant exploration of new medical services, introduction of
Hi-tech equipments which will benefit the patients would certainly
drive the growth in the coming years. The Nursing College also started
M.Sc nursing batch and only two colleges are recommended by the
Rajasthan Government to provide the masters degree in nursing and one
of them is our college.
7. ATTACHMENT OF THE COMPLIANCE CERTIFICATE OBTAINED FROM A COMPANY
SECRETARY IN PRACTICE:
Your Company has employed a whole time Company Secretary. So company
doesn''t require to obtain Compliance Certificate from a Company
Secretary in Practice.
8. FIXED DEPOSITS:
Your Company has not accepted any deposit within the meaning of Section
58A and 58AA of the Companies Act, 1956 and the rules made there under
are not applicable to the Company.
9. COMMENTS ON RESERVATIONS, QUALIFICATIONS OR ADVERSE REMARKS GIVEN
IN THE AUDITORS REPORT:
During the year under review, there was no audit qualification made by
the Auditor in their Report on the Company''s financial statements. The
Company continues to adopt best accounting practices to ensure a regime
of un-qualified financial statements.
10. CORPORATE GOVERNANCE:
The Company has implemented the Corporate Governance requirements.
Management
Discussion and analysis and a report on compliance of Corporate
Governance are enclosed as Annexure to the Director''s Report.
11. DIRECTORS
In accordance with the provisions of the Companies Act, 1956 and the
Articles of Association, Mr. Ashok Agarwal, Dr. Karan Sharma and Mr.
Subhash Chand Jain, Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible offer themselves for
re- appointment.
None of the Directors of the Company is disqualified for being
appointed as Directors as specified in Section 274(1) (g) of the
Companies Act, 1956.
12. DIRECTOR''S RESPONSIBILTYSTATEMENT U/S 217(2AA):
Pursuant to Section 217(2AA) of the Companies Act, 1956 the Directors
based on the representation received from operating management confirm
that:
(i) In the Preparation of Annual Accounts, the applicable accounting
standards had been followed along with proper explanation to the
material departures.
(ii) Directors had in selection of the accounting policies, consulted
the statutory auditors and have applied them consistently and made
judgments and estimates that are reasonable and prudent so as to give a
true and fair view of the state of affairs of the Company at the end of
the financial year and of the profit of the Companyforthe period.
(iii) Directors had taken proper and sufficient care, to the best of
their knowledge and ability, for the maintenance of adequate accounting
records in accordance with the provisions of the Companies Act for
safeguarding the assets of the Company and for preventing and detecting
fraud and other irregularities.
(iv) Directors had prepared the Annual Accounts on a going concern
basis.
13. CONSERVATION OF ENERGY, TECHNOLOGY, FOREIGN EXCHANGE EARNINGS AND
OUTGO:
Since the Company is engaged in medical service sector and has no
activity pertaining to manufacturing hence furnishing of details
pertaining to Conservation of Energy and Technology Absorption are not
applicable as required under Section 217 (1) (e) of the Companies Act,
1956 read with Companies (Disclosure of particulars in the Report of
Board of Directors) Rules 1988. There were no foreign exchange
earnings and outgoing during the year.
14. AUDITORS AND AUDITOR''S REPORT:
M/s Gopal Sharma and Company, Chartered Accountants, the statutory
auditor of the Company holds office until the conclusion of the ensuing
Annual General Meeting. The Observation and comments given by the
Auditor in their report together with notes to Accounts are self
explanatory and hence do not call for any further comments under
Section 217 of the Companies Act, 1956.
The Board on the recommendation of the Audit Committee had proposed
that M/s Gopal Sharma & Co., Chartered Accountants, Jaipur be
re-appointed as the Statutory Auditors of the Company and to hold
office till the conclusion of the next Annual General Meeting of the
Company. M/s Gopal Sharma & Co., Chartered Accountants, Jaipur have
forwarded their certificate to the Company, stating that their
re-appointment, if made, will be within the limit specified in that
behalf in Sub-Section (1B) of the Section 224 of the Companies Act,
1956.
15. PARTICULAR OF EMPLOYEES:
The Company has not paid any remuneration attracting the provisions of
Companies (Particulars of Employees) Rules, 1975 read with Section 217
(2A) of the Companies Act, 1956. Hence no information is required to be
appended to this report in this regard.
16. REPORTS ON PROJECTION MADE IN OFFER DOCUMENTS FOR PUBLIC OR RIGHT
ISSUE BY A LISTED COMPANY:
During the year under review Company had not issued any offer document.
17. REPORT OF THE UTILIZATION OF PROCEEDS ON THE PUBLIC, RIGHT ISSUE
AND PREFERENTIAL ALLOTMENT OF SECURITIES
During the year under review Company had not come up with any public,
right and preferential allotment.
18. DISCLOSURE FOR FAILURE TO COMPLETE BUY-BACK WITHIN TIME:
During the year under review Company had not dealt with any Buy back
proposal.
19. DISCLOSURE FOR ISSUANCE OF SWEAT EQUITY SHARES :
During the year under review Company had not issued any Sweat Equity
Shares.
20. ACKNOWLEDGEMENT
The Board expresses its grateful thanks for the assistance and
co-operation extended by Punjab National Bank & other Banks, various
departments of State & Central Government and other Associations.
Your Directors wish to convey their gratitude and appreciation to all
employees of the Company for their valuable contribution during the
year. They also wish to place on record their appreciation to the
Company''s Customers, Investors, Shareholders, Bankers, Suppliers,
Distributors and other business associates for their cooperation and
support.
Last but not the least Directors wish to place on records their deep
sense of appreciation for the devoted services of Consultant Doctors
and entire Nursing Staff at all levels of the Company for its growth.
BY THE ORDER OF THE BOARD
Sd/- Sd/-
Place : Jaipur (Dr. SHAILENDRA
KR SHARMA) (GANPAT RAI SHARMA)
Date: 13.08.2013 MANAGING DIRECTOR CHAIRMAN
Mar 31, 2010
The Directors are pleased to present the Twenty-First Annual Report on
the business and operations of your Company together with Audited
Annual Accounts and Cash Flow Statement for the year ended on31st
March,2010.
1. FINANCIAL RESULTS
(Rs. in Lacs)
For the year ended on
2009-2010 2008-2009
Professional Receipts & Other Income 910.98 747.95
Profit before Interest,
Depreciation & Tax 207.36 169.13
Less: Interest 89.39 91.33
Operating Profit 117.97 77.80
Less: Depreciation 96.11 71.61
Net Profit before Tax 21.86 6.19
Less: Provision for Taxation:
Current Tax 7.70 2.37
Deferred Tax (Net) 1.04 4.18
Net Profit After Tax 13.12 (0.36)
Add : Profit brought forward
from Previous Year 34.79 35.15
Surplus carried forward to Balance Sheet 47.91 34.79
2. REVIEW OF OPERATION:
During the year under review, your Company has registered an overall
increase of 22 % in the professional and other receipts i.e. Rs 910.98
in comparison to 747.95 Lacs in the previous year Inspite of the stiff
competition in the medical industry affecting the operations of your
Company your Company has performed satisfactorily by maintaining almost
same profit level of the previous year before Interest, Depreciation
and Taxes. Further your Company continuously making efforts to enhance
the operations and also trying to hold its grip over upcoming
3 DIVIDEND:
In view of marginal funds, the Board of Directors doesnt recommend
payment of dividend for the
4. DISCLOSURE OF MATERIAL CHANGES SINCE THE DATE OF BALANCE SHEET:
There is no material changes since the date of Balance Sheet regarding
(a) Disposal of a substantial part of undertaking
(b) Changes in Capital Structure of the Company
(c) Serious break down
(d) Alteration in wage structure arising out of trade union
negotiations
(e) Material changes concerning purchase of raw material and sale of
products, etc.
5. DISCLOSURE OF COMPOSITION OF THE AUDIT COMMITTEE:
The constitution of audit committee is in confirmation with the
requirements of section 292(A) of the Companies Act, 1956 and also as
per the requirements of Clause 49(H) (A) of the listing agreement. The
Audit Committee of the Company consists of 4 Directors; Shri J.N.
Pathak, Shri Ganpat Rai Sharma and Shri Ashok Agarwal and Shri Subhash
Chand Jain., all being Non- Executive. The Committee is chaired by Shri
Ashok Agarwal an Independent Director and Ms Anupriya Saxena has been
nominated as Compliance Officer. All the members of the audit committee
are financially literate and majority of them are having accounting or
related financial management expertise.
6. OUTLOOK FOR 2010-11:
The Company can look back with satisfaction at the last years
performance as being ever improving. The Company is working towards
sustaining this momentum in the current year also. During the year
under review the hospital unit re-equipped with all latest facility
with available high-tech equipments and expertise of all the
specialties and maintained high status in the line. In addition your
Company has successfully started Fifth batch of Physiotherapy College,
fourth batch of B.Sc Nursing College through a trust having same
management, due to this hospital will get highly qualified Nursing
Staff. Your Company is running a successful Cardiac Department through
JAIPUR HEART INSTITUTE. But the vision of management does not stop here
itself. Constant exploration of new medical services, introduction of
Hi-tech equipments which will benefit the patients would certainly
drive the growth in the corning years.
7. ATTACHMENT OF THE COMPLIANCE CERTIFICATE OBTAINED FROM A COMPANY
SECRETARY IN PRACTICE:
Company has employed a full time Company Secretary, So Company doesnt
require to obtain Compliance Certificate obtained from a Company
Secretary in Practice.
8. FIXED DEPOSITS:
Your Company has not accepted any deposit within the meaning of Section
58A of the Companies Act, 1956 and the rules made there under.
9. COMMENTS ON RESERVATIONS, QUALIFICATIONS OR ADVERSE REMARKS GIVEN
IN THE AUDITORS REPORT:
During the year under review, there was no audit qualification in the
Companys financial statements. The Company continues to adopt best
practices to ensure a regime of un-qualified financial statements.
10. CORPORATE GOVERNANCE:
The Company has implemented the Corporate Governance requirements.
Management Discussion and analysis and a report on compliance of
Corporate Governance are enclosed as Annexure to the Directors Report.
11. DIRECTORS
In accordance with the provisions of the Companies Act, 1956 and the
Articles of Association, Mr. Ganpat Rai Sharma, Mr. Subhash Chand Jain
and Mr. Rajesh Sharma, Directors of the Company retires by rotation at
the ensuing Annual General Meeting and being eligible offer themselves
for re-appointment.
None of the Directors of the Company are disqualified for being
appointed as Directors as specified in Section 274(1) (g) of the
Companies Act, 1956.
12 DIRECTORS RESPONSIBILITY STATEMENT U/S 217(2AA):
Pursuant to section 217(2AA) of the Companies Act, 1956 the Directors
based on the representation received from the operating management
confirm that:
(i) That in the Preparation of Annual Accounts, the applicable
accounting standards have been followed along with proper explanation
to the material departures;
(ii) they have in selection of the accounting policies, consulted the
statutory auditors and have applied them consistently and made
judgments and estimates that are reasonable and prudent so as to give a
true and fair view of the state of affairs of the Company at the end of
the financial year and of the profit of the Company for the period;
(iii) they have taken proper and sufficient care, to the best of their
knowledge and ability, for the maintenance of adequate accounting
records in accordance with the provisions of the Companies Act for
safeguarding the assets of the Company and for preventing and detecting
fraud and other irregularities;
(iv) they have prepared the Annual Accounts on a going concern basis.
13 CONSERVATION OF ENERGY, TECHNOLOGY, FOREIGN EXCHANGE EARNINGS AND
OUTGO:
Since the Company is engaged in service activity and has no activity
pertaining to manufacturing hence furnishing of details pertaining to
Conservation of Energy and Technology Absorption are not applicable as
required under Section 217 (1) (e) of the Companies Act 1956 read with
Companies (Disclosure of particulars in the Report of Board of
Directors) Rules 1988. There were no Foreign exchange earning and
outgoing during the year.
14 AUDITORS AND AUDITORS REPORT:
MIs Gopal Sharma and Company, Chartered Accountants, Jaipur. the
Companys Auditors, retires at the conclusion of the forthcoming Annual
General Meeting and are eligible for re-appointment.
The Board on the recommendation of the Audit Committee, had proposed
that MIs Gopal Sharma and Company, Chartered Accountants, Jaipur be
re-appointed as the Statutory Auditors of the Company and to hold
office till the conclusion of the next Annual General Meeting of the
Company Gopal Sharma and Company, Chartered Accountants, Jaipur have
forwarded their certificate to the Company, stating that their
appointment, if made, will be within the limit specified in that behalf
in Sub-Section (1B)of the Section 224 of the Companies Act, 1956.
The notes to accounts referred to in the Auditors are self explanatory
and therefore do not need further comment.
15 PARTICULAR OF EMPLOYEES:
The Company has not paid any remuneration attracting the provisions of
Companies (Particulars of Employees) Rules, 1975, read with section 217
(2A) of the Companies Act, 1956. Hence no information is requrred to be
appended to this report in this regard.
16 REPORTS ON PROJECTION MADE IN OFFER DOCUMENTS FOR PUBLIC OR RIGHT
ISSUE BY A LISTED COMPANY:
During the year under review Company had not issued any offer document.
17 REPORT OF THE UTILIZATION OF PROCEEDS ON THE PUBLIC, RIGHT ISSUE AND
PREFERENTIAL ALLOTMENT OF SECURITIES:
During the year under review Company had not come up with any public,
right and preferential allotment.
18 DISCLOSURE FOR FAILURE TO COMPLETE BUY-BACK WITHIN TIME:
During the year under review Company had not dealt with any Buy back
proposal.
19 DISCLOSURE FOR ISSUANCE OF SWEAT EQUITY SHARES:
During the year under review Company had not issued any Sweat Equity
Shares.
20 The Board expresses it grateful thanks for the assistance and
co-operation extended by Punjab National Bank and other Banks, various
departments of State and Central Government and other Associations.
Your Directors wish to convey their gratitude and appreciation to all
employess of the Company for their valuable contribution during the
year. They also wish to place on record their appreciation to the
Companys Customers Investors, Shareholders, Bankers, Suppliers,
Distributors and other business associates for their cooperation and
support.
Last but not the least Directors wish to place on records their deep
sense of appreciation for the devoted services of Consultant Doctors
and entire Nursing Staff at all levels of the Company for its success.
BY THE ORDER OF THE BOARD
PLACE : JAIPUR (Dr. SHAILENDRA
KUMAR SHARMA) (GANPAT RAI SHARMA)
DATE : 03-08-2010 MANAGING DIRECTOR CHAIRMAN
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Sharma East India Hospitals & Medical Research Ltd. पर और जानकारी
-
Sharma East India Hospitals & Medical Research Ltd. कंपनी का विवरण
- कंपनी का प्रोफाइल
- कंपनी का इतिहास
- मैनेजमेंट टीम
- पूंजी ढांचा
- प्रॉडक्ट मिक्स
- बैंकर/ऑडीटर/रजिस्ट्रार
-
कंपनी का इतिहास
- बीएसई मूल्य इतिहास
-
Sharma East India Hospitals & Medical Research Ltd. मुख्य वित्तीय अनुपात
- अनुपात
-
Sharma East India Hospitals & Medical Research Ltd. परिणाम
- तिमाही परिणाम
- छहमाही परिणाम
- नौ महीने के परिणम
- वार्षिक परिणाम
-
Sharma East India Hospitals & Medical Research Ltd. Financial Data
- ऑडिट के परिणाम
- नकदी प्रवाह
- बैलेंस शीट
-
Sharma East India Hospitals & Medical Research Ltd. की रिपोर्ट
- लेखा नीति
- ऑडीटर की रिपोर्ट
- निदेशक की रिपोर्ट
- खाते के लिये नोट
-
Sharma East India Hospitals & Medical Research Ltd. कॉर्पोरेट घोषणाएं
- बुक क्लोज़र
- बोर्ड की मीटिंग
-
Stock Market Crash: जंग का असर बाजार में हाहाकार, सेंसेक्स 2500 अंक से ज्यादा लुढ़का, निफ्टी 700 अंक क्रैश -
Stock Market Outlook: होर्मुज स्ट्रेट में संकट! क्या आने वाला है भारतीय शेयर बाजार में बड़ा गिरावट का दौर? -
मिडिल ईस्ट के बढ़ते तनाव ने बिगाड़ा बाजार का मूड, सेंसेक्स 1500 अंक लुढ़का, निफ्टी भी बुरी तरह फिसला -
Stock Market Today: मिडिल ईस्ट तनाव! शेयर बाजार में कोहराम, सेंसेक्स 900+ अंक टूटा, निफ्टी 24,900 के नीचे -
Stock Market: Anthropic के दावे से बढ़ी टेंशन! Nifty-Sensex में बड़ी गिरावट, शेयर बाजार किन 5 कारणों से धड़ाम? -
Stock Markets Today: कारोबारी हफ्ते की शानदार शुरुआत, Sensex और Nifty 50 जबरदस्त बढ़त के साथ बंद -
Stock Alert: सस्ते में मिल रहे Nifty 50 के कई शेयर, यहां से होगी पैसों की बारिश? -
Stock Market Crash: बाजार में हाहाकार, सेंसेक्स 1,200 प्वाइंट से ज्यादा गिरा, निफ्टी भी 400 अंक क्रैश -
Stock Markets Today: बढ़त के साथ बंद हुआ बाजार, Sensex और Nifty की शानदार क्लोजिंग -
Stock Markets Today: Nifty वीकली एक्सपायरी के दिन बाजार में तेजी, IT और PSU इंडेक्स बढ़त के साथ बंद -
Defence Stock: Cochin Shipyard के शेयर में जबरदस्त उछाल, रक्षा मंत्रालय से बड़ा ऑर्डर -
Stock Markets Today: कारोबारी हफ्ते के पहले दिन बाजार की शानदार क्लोजिंग, Sensex और Nifty बढ़त के साथ बंद -
अमेरिका संग ट्रेड डील से SENSEX-NIFTY में दिखा जोश, इन 9 स्टॉक्स में लगा 20% का अपर सर्किट, आपके पास है कोई? -
Stock Market News: India-US ट्रेड डील का असर...शेयर बाजार में जबरदस्त रैली, निवेशकों को 20 लाख करोड़ का फायदा! -
Stock Market News: भारी गिरावट के बाद वापसी, सेंसेक्स-निफ्टी दिन के निचले स्तर से रिकवर, तेजी के पीछे का कारण? -
Stock Market: मोदी सरकार के 15 बजट में कब शेयर बाजार का प्रदर्शन रहा सबसे बेहतर; कब रहा सबसे खराब? फुल रिपोर्ट
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Sign in with Google- Male
- Female
- Others
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+